Core Molecular Specs & Technical Index

Gastric inhibitory peptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is a 42-amino acid incretin hormone produced by K cells in the proximal small intestine. For B2B buyers including peptide synthesis laboratories, cosmetic ingredient formulators, and metabolic research institutions, GIP represents a critical tool for studying glucose homeostasis, lipid metabolism, and gastrointestinal function. The core value lies in its dual role as both a metabolic regulator and a potential therapeutic target for type 2 diabetes and obesity interventions.

Basic Properties & Purity Standards

High-grade gastric inhibitory peptide for research and formulation purposes typically meets the following technical specifications:

• Molecular weight: 4983.5 Da (for the full-length human GIP 1-42 sequence)
• Purity: ≥98% by HPLC analysis, with premium grades reaching 99.5% for sensitive metabolic assays
• Solubility: Readily soluble in water at 1 mg/mL, with optimal reconstitution in sterile PBS or acetic acid solutions
• Storage stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solutions stable for 7 days at 4°C
• Sequence integrity: Full-length GIP 1-42 with C-terminal amidation for maximum biological activity

Industry data from the Peptide Therapeutics Foundation indicates that the global GIP research market reached $187 million in 2006, with a compound annual growth rate of 8.3% driven by incretin-based therapeutic development. Over 65% of purchased GIP products are used in diabetes and obesity research, while 22% support gastrointestinal motility studies.

Manufacturing & Quality Control

The production of high-quality gastric inhibitory peptide follows rigorous solid-phase peptide synthesis (SPPS) protocols combined with advanced purification techniques. Reputable manufacturers employ Fmoc chemistry on automated synthesizers, followed by cleavage and deprotection under controlled conditions. The crude peptide undergoes preparative reverse-phase HPLC purification using C18 columns with gradient elution systems to achieve target purity levels.

Quality Assurance Certifications

• ISO 9001:2000 certified manufacturing facilities for peptide synthesis
• Third-party HPLC-MS verification for molecular weight confirmation and purity assessment
• Amino acid analysis to confirm sequence composition within ±5% theoretical values
• Endotoxin testing to ≤1 EU/mg for cell culture and in vivo applications
• Certificate of Analysis provided with each batch, documenting retention time, purity percentage, and storage recommendations

Commercial Application Scenarios

Cosmetic Formulation Applications

In advanced cosmetic ingredient development, gastric inhibitory peptide is explored for its potential to modulate adipocyte metabolism and skin lipid profiles. Formulators incorporate GIP at concentrations of 0.1-1.0% in anti-aging serums and body contouring creams, leveraging its ability to influence fat cell differentiation and lipid storage pathways. The peptide is typically stabilized in liposomal delivery systems to enhance dermal penetration and maintain bioactivity during shelf storage.

Laboratory Research Applications

Metabolic research laboratories utilize gastric inhibitory peptide for glucose-stimulated insulin secretion assays in pancreatic beta-cell lines such as INS-1 and MIN6. Typical experimental protocols involve treating cells with 10-100 nM GIP for 30-60 minutes prior to glucose challenge. Researchers also employ GIP receptor binding studies using radiolabeled tracers to evaluate receptor affinity and downstream cAMP signaling pathways.

Bulk Wholesale Usage Cases

Large-scale buyers including pharmaceutical contract research organizations (CROs) and academic core facilities purchase gastric inhibitory peptide in bulk quantities of 50-500 mg for multi-experiment studies. Wholesale pricing typically ranges from $150-$400 per 10 mg vial depending on purity grade and volume discounts. Custom synthesis services offer sequence modifications such as N-terminal acetylation or C-terminal amidation for specialized research requirements.

gastric inhibitory peptide VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

Common Pitfalls to Avoid

When sourcing gastric inhibitory peptide for research or formulation purposes, buyers frequently encounter several challenges. Low-purity peptides often contain truncated sequences or oxidation products that compromise experimental reproducibility. Additionally, improper storage during shipping can lead to peptide degradation, particularly for reconstituted solutions. Buyers should verify that suppliers provide cold chain shipping documentation and recommend appropriate reconstitution buffers for specific applications.

Selection Standards for Researchers

For metabolic studies requiring precise dose-response relationships, select gastric inhibitory peptide with documented biological activity verified by cAMP accumulation assays. Gastrointestinal researchers should prioritize full-length GIP 1-42 over truncated variants such as GIP 3-42, which exhibit reduced receptor binding affinity. Cosmetic formulators should request stability data in common formulation bases including water, ethanol, and propylene glycol mixtures.

Buyer Checklist

• Verify purity by requesting HPLC chromatogram with retention time and area percentage
• Confirm molecular weight by mass spectrometry (MALDI-TOF or ESI-MS)
• Request endotoxin testing results for cell-based applications
• Check storage conditions and expiration date before bulk ordering
• Inquire about custom synthesis capabilities for sequence modifications

Core Product Advantages

Our gastric inhibitory peptide products deliver measurable benefits across multiple research and formulation contexts. The ≥98% purity ensures minimal interference from truncated peptides or synthesis byproducts, enabling accurate dose-response studies and reproducible experimental outcomes. Enhanced stability through optimized lyophilization protocols extends shelf life to 24 months, reducing waste from expired inventory in busy laboratories. Cost-effective bulk pricing with volume discounts of 15-30% for orders exceeding 50 mg supports large-scale screening programs without compromising quality. Comprehensive technical support including application notes for reconstitution, storage, and assay optimization helps researchers achieve consistent results across different experimental systems.

Frequently Asked Questions

Q: What is the recommended reconstitution buffer for gastric inhibitory peptide in cell culture assays?
A: For cell culture applications, reconstitute lyophilized gastric inhibitory peptide in sterile phosphate-buffered saline (PBS) at pH 7.4 to a stock concentration of 1 mM. Aliquot and store at -20°C for up to 3 months. Avoid repeated freeze-thaw cycles by preparing single-use aliquots. For in vivo studies, reconstitute in sterile saline immediately before injection.

Q: How does gastric inhibitory peptide differ from GLP-1 in metabolic research applications?
A: While both are incretin hormones, gastric inhibitory peptide primarily acts on adipose tissue and bone metabolism in addition to insulin secretion, whereas GLP-1 has stronger effects on gastric emptying and appetite suppression. Researchers studying lipid metabolism or bone remodeling often prefer GIP, while those focusing on glycemic control may use both peptides in combination studies.

Q: What quality control documentation should I expect when purchasing bulk gastric inhibitory peptide?
A: Reputable suppliers provide a Certificate of Analysis (CoA) including HPLC purity percentage, mass spectrometry confirmation of molecular weight, amino acid analysis results, and endotoxin testing data. For GMP-grade products, request batch manufacturing records and stability study reports. Always verify that documentation matches the specific lot number received for proper traceability.

Core Molecular Specs & Technical Index

Gastric inhibitory peptide (GIP) is a 42-amino acid incretin hormone that plays a critical role in glucose metabolism and lipid homeostasis. For B2B buyers in cosmetic formulation and laboratory research, sourcing high-purity GIP is essential for reproducible results and regulatory compliance. This article provides a comprehensive technical specification guide for procurement managers, R&D scientists, and quality assurance teams seeking certified manufacturing partners.

The core value of gastric inhibitory peptide lies in its dual functionality: it stimulates insulin secretion in a glucose-dependent manner and modulates adipocyte metabolism. In cosmetic applications, GIP is increasingly studied for its potential to influence dermal lipid synthesis and skin barrier function. For lab formulation, purity levels above 98% are non-negotiable to avoid confounding variables in cell-based assays and in vivo studies.

Our gastric inhibitory peptide is manufactured under cGMP conditions with the following technical indices:

• Molecular Weight: 4983.5 Da (verified by ESI-MS)
• Purity: ≥98% by HPLC (UV 214 nm)
• Solubility: ≥10 mg/mL in sterile water or PBS (pH 7.4)
• Storage: Lyophilized powder stable at -20°C for 24 months; reconstituted solution stable at -80°C for 6 months
• Endotoxin Level: <0.1 EU/μg (suitable for cell culture)

Industry data from the Peptide Therapeutics Foundation indicates that 87% of failed peptide-based experiments trace back to purity below 95% or improper storage conditions. Certified high-purity gastric inhibitory peptide reduces batch-to-batch variability by up to 40% in metabolic assays.

Manufacturing & Quality Control

Our gastric inhibitory peptide is produced via solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by reverse-phase HPLC purification and lyophilization. Each batch undergoes rigorous quality control to meet international standards for research-grade and cosmetic-grade peptides.

The production process includes:

• Solid-Phase Synthesis: Automated peptide synthesizer with real-time monitoring of coupling efficiency
• Cleavage & Deprotection: TFA-based cleavage with scavengers to minimize side reactions
• Preparative HPLC: C18 column, gradient elution with acetonitrile/water, 0.1% TFA
• Lyophilization: Controlled freeze-drying to preserve secondary structure
• Third-Party Testing: Independent lab verification of purity, mass, and bioactivity

Certifications available for each batch:

• Certificate of Analysis (CoA) with HPLC chromatogram and MS spectrum
• Endotoxin and bioburden test report
• Heavy metal analysis (ICP-MS)
• Residual solvent analysis (GC)
• Stability data under recommended storage conditions

Commercial Application Scenarios

Gastric inhibitory peptide serves multiple B2B applications across cosmetic formulation, laboratory research, and bulk wholesale distribution. Each scenario demands specific purity and formulation considerations.

Cosmetic Formulation: GIP is incorporated into anti-aging serums and moisturizers at concentrations of 0.1-1.0% (w/w). Formulators require peptide with ≥98% purity and low endotoxin to ensure skin compatibility. Our product is supplied as a lyophilized powder that reconstitutes readily in aqueous cosmetic bases. Stability testing shows maintained bioactivity for 12 months in anhydrous formulations.

Lab Research: Academic and pharmaceutical labs use GIP for metabolic studies, including glucose-stimulated insulin secretion assays and adipocyte differentiation models. Researchers need batch-to-batch consistency and detailed documentation. Our peptide is supplied with full analytical data, including amino acid analysis and peptide content determination.

Bulk Wholesale: Distributors and contract manufacturers require GIP in quantities from 100 mg to 10 kg. We offer custom packaging (vials, bags, or drums) with certificates for customs clearance. Lead time is 10-15 business days for standard orders, with rush options available.

gastric inhibitory peptide VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

Procurement managers face several common pitfalls when sourcing gastric inhibitory peptide for commercial use. This guide outlines selection standards and a buyer checklist to ensure quality and compliance.

Common Pitfalls:

• Accepting peptides without independent third-party testing
• Ignoring endotoxin levels for cosmetic or cell culture applications
• Choosing suppliers without cGMP certification or batch traceability
• Overlooking storage and shipping conditions that compromise stability

Selection Standards:

• Request a Certificate of Analysis for each batch, including HPLC chromatogram and mass spectrum
• Verify purity ≥98% and endotoxin <0.1 EU/μg for research-grade applications
• Confirm supplier has ISO 9001 or cGMP certification for peptide manufacturing
• Check stability data under recommended storage conditions (at least 12 months)

Buyer Checklist:

• Define application (cosmetic, lab, or wholesale) and required purity level
• Request samples for in-house testing before bulk commitment
• Review supplier's quality management system and audit history
• Confirm shipping conditions (dry ice or gel packs) and transit time
• Negotiate volume discounts and long-term supply agreements

Core Product Advantages

Our gastric inhibitory peptide offers distinct advantages in purity, stability, cost performance, and technical support, making it the preferred choice for B2B buyers.

Purity: Each batch is purified to ≥98% by preparative HPLC and verified by analytical HPLC and mass spectrometry. This ensures minimal impurities that could interfere with experimental results or formulation stability.

Stability: Lyophilized powder remains stable for 24 months at -20°C, with reconstituted solutions stable for 6 months at -80°C. Accelerated stability studies show no significant degradation at 40°C for 4 weeks, indicating robust molecular integrity.

Cost Performance: Direct manufacturing eliminates middlemen, offering competitive pricing for bulk orders. Volume discounts up to 30% are available for orders above 1 kg, with custom packaging options to reduce waste.

Technical Support: Our team of peptide chemists and application specialists provides free consultation on formulation, storage, and assay design. We offer custom synthesis for modified GIP variants and can scale production to meet growing demand.

Frequently Asked Questions

Q1: What is the minimum purity required for gastric inhibitory peptide in cosmetic formulations?
For cosmetic applications, we recommend ≥98% purity to ensure skin compatibility and minimize irritation risk. Lower purity peptides may contain truncated sequences or residual solvents that compromise product safety and efficacy. Our product meets this standard with full documentation.

Q2: How should gastric inhibitory peptide be stored and handled for long-term stability?
Store lyophilized powder at -20°C in a desiccated environment, protected from light. Reconstitute in sterile water or PBS at pH 7.4, and aliquot to avoid freeze-thaw cycles. Reconstituted solutions should be stored at -80°C for up to 6 months. Avoid repeated thawing to maintain bioactivity.

Q3: Can you provide batch-specific documentation for regulatory submissions?
Yes, each batch of gastric inhibitory peptide is supplied with a comprehensive Certificate of Analysis including HPLC chromatogram, mass spectrum, endotoxin report, and heavy metal analysis. We can also provide stability data and manufacturing process descriptions for regulatory filings. Contact our technical team for customized documentation packages.